## Clinical Assessment **Key Point:** Bilateral nasal polyps presenting for the first time (no prior medical therapy documented) should be managed with a stepwise approach — oral corticosteroids followed by intranasal steroids — before surgical intervention is considered. This patient has benign nasal polyps confirmed on biopsy with: - Bilateral presentation (suggests allergic or chronic inflammatory etiology) - 6 months of symptoms (chronic, but **no mention of prior medical therapy**) - Significant functional impairment (obstruction, post-nasal drip) - No bone erosion on imaging (rules out malignancy or invasive disease) ## Management Algorithm The standard stepwise approach for chronic rhinosinusitis with nasal polyps (CRSwNP): 1. **First-line:** Intranasal corticosteroids (INCS) ± short course of oral corticosteroids 2. **If inadequate response:** FESS with complete polyp removal 3. **Post-operative:** INCS maintenance + endoscopic follow-up ## Why Oral Corticosteroids Followed by Intranasal Steroids is the Best Next Step **High-Yield:** Per EPOS (European Position Paper on Rhinosinusitis and Nasal Polyps) guidelines and standard ENT practice, oral corticosteroids (prednisolone 0.5 mg/kg/day for 2–4 weeks) are the most effective medical treatment for reducing polyp size and symptom burden. They are indicated as first-line therapy when polyps are symptomatic and no prior medical treatment has been tried. 1. **Oral corticosteroids** — Rapidly reduce polyp size and mucosal edema, providing significant symptomatic relief. A short course (4 weeks) is safe and effective. 2. **Followed by intranasal steroids** — Maintenance therapy with INCS (e.g., fluticasone, mometasone) reduces recurrence and sustains the benefit achieved with oral steroids. 3. **Surgery is reserved for failure of medical therapy** — FESS (Option B) is the gold standard but is indicated only after adequate medical therapy has been tried and failed. The stem does not state that medical therapy was previously attempted. 4. **Allergy testing (Option D)** — Not the immediate next step; allergy workup may be done concurrently but does not address the acute symptom burden. 5. **Intranasal steroids alone (Option A)** — Appropriate for mild disease; however, given 6 months of significant bilateral obstruction, a combined oral + intranasal steroid approach is more appropriate as the best next step. **Clinical Pearl:** The "best next step" in a patient with nasal polyps and no documented prior medical therapy is always medical management first. FESS is indicated when medical therapy fails (typically after 12 weeks of adequate INCS ± oral steroids). This follows the principle of stepwise escalation in CRSwNP management (EPOS 2020 guidelines; Scott-Brown's Otolaryngology, 8th ed., Ch 4.7). ## Post-treatment Follow-up - Reassess at 4–6 weeks after completing oral steroids - If adequate response: continue INCS long-term - If inadequate response or recurrence: proceed to FESS with wide middle meatal antrostomy - Identify and manage underlying allergies or asthma (consider IgE testing at follow-up) [cite: EPOS 2020 Guidelines; Scott-Brown's Otolaryngology, 8th ed., Ch 4.7; KD Tripathi Essentials of Medical Pharmacology]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.